NASDAQ · Medical - Devices

Axogen, Inc. (AXGN) Stock

$36.13 -0.14% NASDAQ: AXGN Healthcare

Valuation

MetricValue
Price$36.13
Market Cap$1.94B
P/E Ratio-55.71
P/B Ratio7.82
P/S Ratio8.05
EPS (TTM)$0.00
52-Week High$52.91
52-Week Low$15.27
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-17.88%
ROA-11.00%
ROCE-4.68%
Gross Margin75.01%
Operating Margin-3.79%
Net Margin-13.36%
Debt/Equity0.08
Current Ratio5.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$127.0M$139.0M$159.0M$187.0M$225.0M
Operating Profit$-25.0M$-30.0M$-21.0M$-3.0M$-8.0M
Net Profit$-27.0M$-29.0M$-22.0M$-10.0M$-16.0M
EPS$-0.65$-0.69$-0.51$-0.23$-0.34
Op Margin-20.0%-21.4%-13.5%-1.8%-3.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$208.0M$195.0M$197.0M$204.0M$222.0M
Total Liabilities$95.0M$94.0M$101.0M$100.0M$93.0M
Cash$33.0M$15.0M$31.0M$28.0M$36.0M
Borrowings$67.0M$67.0M$69.0M$69.0M$68.0M

Latest News

Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026 GlobeNewswire · Jul 15, 2026 Dow Jones AI Giant Nvidia Stock Tumbles To Key Support Level Amid Market Sell-Off Investor's Business Daily · Jun 9, 2026 Eli Lilly Leads Medical Stocks To Watch, While Google Finds Support Investor's Business Daily · Jun 6, 2026 AxoGen, Stock Of The Day, Offers Entry After Bullish Rebound Investor's Business Daily · Jun 5, 2026 AxoGen Says Nerve Repair Strategy Intact as Reimbursement Wins Gather Steam MarketBeat · May 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-13.0M$-16.0M$-6.0M$5.0M$1.0M
Investing Cash Flow$-52.0M$-24.0M$4.0M$-15.0M$-9.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-17.0M$-17.0M$15.0M$-3.0M$6.0M
Free Cash Flow$-42.0M$-37.0M$-21.0M$0$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.26
EV / EBITDA-131.77
FCF Yield0.12%
Quick Ratio5.04
Interest Coverage-1.02
Return 1Y213.96%
Return 3Y349.43%
Return 5Y98.34%

Ownership

Insiders Held2.19%
Institutions Held93.86%
Institutions Float Held95.96%
Institutional HolderSharesReport Date
First Light Asset Management, LLC4,002,7682026-03-31
Blackrock Inc.3,870,8512026-03-31
Morgan Stanley3,122,9822026-03-31
Vanguard Capital Management LLC2,291,5632026-03-31
ArrowMark Colorado Holdings LLC1,915,4392026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Axogen, Inc.

Axogen, Inc. (AXGN) stock trades at $36.13 with a market capitalization of $1.94B. The stock is valued at a price-to-earnings (P/E) ratio of -55.71, price-to-book of 7.82, price-to-sales of 8.05. Over the past 52 weeks the stock has ranged between $15.27 and $52.91, and currently trades 31.7% below its 52-week high.

On profitability, Axogen, Inc. generates a return on equity (ROE) of -17.88%, return on capital employed of -4.68%, an operating margin of -3.79%, a net profit margin of -13.36%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides